TG Therapeutics Inc (NASDAQ:TGTX)

15.59
Delayed Data
As of Mar 05
 +0.74 / +4.98%
Today’s Change
4.42
Today|||52-Week Range
18.88
-1.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
Operating ActivitiesNet Income / Starting Line-889.1K-26.2M-20.5M--
 
 
 
 
Depreciation--235.001.1K--
 
 
 
Total Other Cash Flow390.6K20.4M5.5M--
 
 
 
 
Funds From Operations-498.5K-5.8M-15.0M--
 
 
 
 
Funds From/For Other Operating Expenses-411.9K-644.0K-4.2M--
 
 
 
 
Net Cash Flow - Operating Activities-86.6K-5.2M-10.8M--
 
 
 
 
 
InvestingIncrease In Investments0.000.00-4.9M--
 
 
Capital Expenditures0.00-1.4K-5.7K--
 
 
 
Fixed Asset Disposal10.4K0.00----
 
 
Net Cash Flow Investing10.4K-1.4K-4.9M--
 
 
 
 
 
FinancingShort Term Borrowings0.00-200.0K0.00--
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale9.8M12.2M39.9M--
 
 
 
 
Common Preferred Redeemed0.00-84.5K-149.8K--
 
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing9.8M11.9M39.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.00----
 
Net Change In Cash9.7M6.7M24.0M--
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account